The Rise and Fall of Theranos and Uber's Turbulence

This chapter explores the controversial rise of Theranos, a biotech company that promised groundbreaking blood testing technology but was later exposed for deception, alongside the turbulent events surrounding Uber in 2017. It highlights the intersection of technology, investment risks, and accountability, reflecting on how both companies faced severe scrutiny and legal challenges due to unethical practices. Additionally, the chapter underscores the broader implications of corporate culture and the necessity for due diligence in the tech industry.